Share on StockTwits
 

McKesson Corp. (NYSE:MCK) Director Alton F. Irby III unloaded 1,300 shares of the stock in a transaction that occurred on Wednesday, January 22nd. The stock was sold at an average price of $167.98, for a total transaction of $218,374.00. Following the transaction, the director now directly owns 25,599 shares in the company, valued at approximately $4,300,120. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

McKesson Corp. (NYSE:MCK) traded up 1.59% during mid-day trading on Thursday, hitting $172.37. The stock had a trading volume of 3,469,241 shares. McKesson Corp. has a 52-week low of $101.46 and a 52-week high of $177.00. The stock’s 50-day moving average is $163.4 and its 200-day moving average is $142.0. The company has a market cap of $39.595 billion and a P/E ratio of 28.84.

Several analysts have recently commented on the stock. Analysts at Zacks downgraded shares of McKesson Corp. from an “outperform” rating to a “neutral” rating in a research note to investors on Friday, January 17th. They now have a $177.00 price target on the stock. Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of McKesson Corp. in a research note to investors on Tuesday, January 14th. They now have a $180.00 price target on the stock, down previously from $190.00. Finally, analysts at UBS AG cut their price target on shares of McKesson Corp. from $190.00 to $187.00 in a research note to investors on Tuesday, January 14th. They now have a “buy” rating on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $165.00.

McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.